3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Solid Tumor
1
Glioblastoma
1
Interventions
pembrolizumab
10
Docetaxel
8
senaparib
7
Injections
7
Capecitabine
7
Paclitaxel
6
Cisplatin
6
Irinotecan
5
Fluorouracil
5
Leucovorin
4
Cyclophosphamide
4
Bevacizumab
4
tislelizumab
3
pertuzumab
3
fludarabine
3
atezolizumab
3
Rifampin
3
Oxaliplatin
3
Itraconazole
3
Gemcitabine
3
ontuxizumab
2
navoximod
2
fluzoparib
2
durvalumab
2
Trastuzumab
2
Nivolumab
2
Midazolam
2
Hydroxychloroquine
2
Carboplatin
2
130-nm albumin-bound paclitaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Solid Tumor
×
MK-4166
×
Clear all
NCT02132754
2021-01-28
MK-4166-001
Merck Sharp & Dohme LLC
Phase 1
Completed
116 enrolled
61 charts